Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Antenna for an automobile
Cellulose acylate laminate film, method for producing cellulose acylate laminate film, polarizer and liquid crystal display device
Code reading apparatus, sales registering apparatus, and sales registering method
Polymeric compositions including their uses and methods of production
Display screen with graphical user interface
Device with a floating head having a heater element
Manufacturing method power semiconductor device
  Randomly Featured Patents
Fork lift truck
Extended database search
Process for improving lubricating base oil quality
Method and apparatus for adjusting parameters used by compositing devices
Electronic paper towel dispenser
Solid forms of an N-(phenylmethyl)propanamide derivative and processes of preparation
Method for preventing or reducing acute renal failure by administration of therapeutically active .alpha.-MSH analogues
Preparation of epoxy resins
Method of producing crisp reheated french fried potatoes
Tray structure